跳到正文
原文
Nature Medicine· Barry A. Borlaug·· 12 天前精选AI 评分75

semaglutide在心力衰竭保留射血分数和肥胖患者中的血流动力学效应:一项安慰剂对照随机临床试验

Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial

AI 导读

semaglutide在心力衰竭保留射血分数和肥胖患者中显著改善了低强度运动期间的肺动脉楔压和其他血流动力学参数。

推荐理由

报道了semaglutide在心力衰竭保留射血分数和肥胖患者中的临床试验结果,提供新的治疗数据。

正文 · 原文

Nature Medicine, Published online: 08 November 2026; doi:10.1038/s41591-026-04762-3

As presented at the 2026 American Heart Association Scientific Sessions, in a placebo-controlled randomized clinical trial, semaglutide significantly improved pulmonary artery wedge pressure and other hemodynamic parameters during low-intensity exercise in individuals with heart failure with preserved ejection fraction and obesity.

来源:Nature Medicine · nature.com